Mednet Logo
TRIALMATCH

A better way to find cancer trials

Open, enrolling trials for the patient in front of you.

Funded byNational Cancer Institute
HOW IT WORKS

Patient in, trials out

Describe your patient in plain language and let TrialMatch check the eligibility fine print.

Match on everything that matters

Get as specific as you want. Every detail you add narrows the field, and TrialMatch weighs all of it across every actively enrolling trial.

DiagnosisStageBiomarkersPrior therapyLab valuesCardiac functionPerformance statusComorbiditiesTiming windowsDistanceAge

Trials that find you

No time to search? Enrolling trials still surface inside Mednet's 22,000+ clinical discussions, keeping you in the loop even when it's not top of mind.

Mednet Community
Medical Oncology

Would you ever omit adjuvant pembrolizumab after pCR in localized TNBC?

TrialMatch

AI-matched trials from this thread

NIH
Phase 3Recruiting

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage TNBC

Location: New York, New York

View Trial Options

Why it matters

“I am committed to reducing administrative burdens related to cancer clinical trials. NCI SBIR-funded [Mednet] is helping with TrialMatch, a new AI-assisted tool that makes it faster and easier for doctors to find trials for their patients.”

National Cancer Institute

This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N91024C00071.

See what's enrolling near you

Join Mednet to start your first search.